Head-to-Head breast cancer drug battle: which works better before surgery?
NCT ID NCT07416253
Summary
This study compares two newer targeted drugs for HER2-positive breast cancer when given before surgery. It aims to see which drug helps more patients achieve a complete disappearance of cancer in the breast and lymph nodes after treatment. The trial will also track side effects and long-term cancer control in 68 participants.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.